User profiles for "author:Satoshi Morita"

Satoshi Morita

Graduate School of Science and Technology, Keio University
Verified email at keio.jp
Cited by 1175

Mathematical foundation of quantum annealing

S Morita, H Nishimori - Journal of Mathematical Physics, 2008 - pubs.aip.org
Quantum annealing is a generic name of quantum algorithms that use quantum-mechanical
fluctuations to search for the solution of an optimization problem. It shares the basic idea …

[HTML][HTML] Gefitinib or chemotherapy for non–small-cell lung cancer with mutated EGFR

M Maemondo, A Inoue, K Kobayashi… - … England Journal of …, 2010 - Mass Medical Soc
Background Non–small-cell lung cancer with sensitive mutations of the epidermal growth
factor receptor (EGFR) is highly responsive to EGFR tyrosine kinase inhibitors such as …

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis

K Oba, X Paoletti, S Alberts, YJ Bang… - Journal of the …, 2013 - academic.oup.com
Background In investigations of the effectiveness of surgery and adjuvant chemotherapy for
gastric cancers, overall survival (OS) is considered the gold standard endpoint. However …

Laparoscopic surgery for gastric cancer: a collective review with meta-analysis of randomized trials

Y Kodera, M Fujiwara, N Ohashi… - Journal of the …, 2010 - journals.lww.com
Advances in surgical technique can be followed by long periods of catch-up as clinicians
learn how to use new techniques appropriately. Despite the successful use of laparoscopy …

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an …

T Mitsudomi, S Morita, Y Yatabe, S Negoro… - The lancet …, 2010 - thelancet.com
Background Patients with non-small-cell lung cancer harbouring mutations in the epidermal
growth factor receptor (EGFR) gene respond well to the EGFR-specific tyrosine kinase …

Midterm outcomes in patients with intermediate‐sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation …

M Morimoto, K Numata, M Kondou, A Nozaki, S Morita… - Cancer, 2010 - Wiley Online Library
BACKGROUND: To improve the efficacy of radiofrequency ablation (RFA) for the treatment
of intermediate‐sized hepatocellular carcinomas (HCCs), the authors compared RFA …

[PDF][PDF] Safety and antitumor activity of anti–PD-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer

J Hamanishi, M Mandai, T Ikeda, M Minami… - Journal of Clinical …, 2015 - researchmap.jp
Purpose Programmed death-1 (PD-1), a coinhibitory immune signal receptor expressed in T
cells, binds to PD-1 ligand and regulates antitumor immunity. Nivolumab is an anti–PD-1 …

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an …

H Saito, T Fukuhara, N Furuya, K Watanabe… - The Lancet …, 2019 - thelancet.com
Background Resistance to first-generation or second-generation EGFR tyrosine kinase
inhibitor (TKI) monotherapy develops in almost half of patients with EGFR-positive non-small …

Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model

T Kikuchi, A Morizane, D Doi, H Magotani, H Onoe… - Nature, 2017 - nature.com
Induced pluripotent stem cells (iPS cells) are a promising source for a cell-based therapy to
treat Parkinson's disease (PD), in which midbrain dopaminergic neurons progressively …

[PDF][PDF] First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for …

A Inoue, K Kobayashi, K Usui, M Maemondo… - J Clin …, 2009 - researchgate.net
Purpose This multicenter phase II study was undertaken to investigate the efficacy and
feasibility of gefitinib for patients with advanced non–small-cell lung cancer (NSCLC) …